This compound is a deuterated pharmaceutical intermediate, specifically a heptadeuterated analog of a propan-2-ylamino derivative. Its significance lies in its use as a building block in the synthesis of deuterated drugs, where the incorporation of deuterium atoms can influence metabolic stability.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1185031-19-9
1-(2-Isopropyl-1,3-thiazol-4-yl)-N-methylmethanamine dihydrochloride
Pharmaceutical intermediate for olanzapine synthesis
2-Methyl-N-(phenylmethylene)alanine-d6 Ethyl Ester
Pharmaceutical intermediate
Methyl 4-(acetylamino)-5-(ethylsulfonyl)-2-methoxybenzoate
Pharmaceutical intermediate for amisulpride impurities
Boc-Orn(2-Cl-Z)-OH
Protected amino acid for peptide synthesis
Pindolol
beta-adrenergic antagonist active pharmaceutical ingredient
1-(1,1,1,2,3,3,3-heptadeuteriopropan-2-ylamino)-3-(1H-indol-4-yloxy)propan-2-ol
JZQKKSLKJUAGIC-SVMCCORHSA-N
[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])NCC(COC1=CC=CC2=C1C=CN2)O
—